Seegene Inc
Contact

Not Available for sale in the United States

  • Real-time
    PCR
  • CE-IVD
    marked

Anyplex™ II
MTB/XDR Detection

Simultaneous detection of MTB and 13 mutations associated with XDR-TB

Anyplex™II MTB/XDR Detection simultaneously detects and identifies Mycobacterium tuberculosis (MTB) and 13 mutations associated with XDR-TB. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control.

Features

Result

These results indicate the detection of MTB infection in the FAM channel, and the Fluoroquinolone-resistance mutation in the HEX channel and the Injectable drug-resistance-R2* mutation in the Cal Red 610 channel.

(* High level Kanamycin, Amikacin, Capreomycin resistance)

Publication

- gyrA Gene Mutation Conferring Phenotypic Cross-Resistance among Fluoroquinolones (Ofloxacin, Levofloxacin and Gatifloxacin) in Multidrug Resistant Mycobacterium tuberculosis Strains Isolated from Pulmonary MDR-TB Patients in Bangladesh

Note

[1] The WTC is designed to be exhibited the same result pattern with drug-susceptible M. tuberculosis sample. The WTC reaction should be always performed in each testing run, and the drug-resistant result of unknown samples is analyzed on the basis of the result of WTC.

[2] Extensively Drug Resistance